Szent-Györgyi Prize for Progress in Cancer Research

The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new directions. The Szent-Györgyi Prize honors researchers whose discoveries have made possible new approaches to preventing, diagnosing and/or treating cancer. The Prize recipient is honored at a formal dinner and award ceremony and receives a $25,000 cash prize. In addition, the recipient leads the next "Szent-Györgyi Prize Committee" as honorary chairman.[1]

The Szent-Györgyi Prize is named in honor of Albert Szent-Györgyi, M.D., Ph.D. was a pioneer who challenged the conventional thinking of the day to pursue his novel ideas. After winning the Nobel Prize for his study on vitamin C and cell respiration, Dr. Szent-Györgyi set his sights on finding a way to defeat cancer. He was a leading advocate for developing resources to provide scientists with the financial support necessary to pursue novel cancer research ideas and in 1973 co-founded NFCR with entrepreneur Franklin C. Salisbury. Since then, NFCR has provided more than $300 million in support of cancer research and prevention education programs.

NFCR established the Szent-Györgyi Prize to honor scientists who have made extraordinary progress in cancer research and to focus attention on the essential role of basic research in finding the answers to the mysteries of cancer. The Prize is also intended to stimulate continued investment in the pioneering research in the hope of producing scientific breakthroughs and lead to a deeper understanding of the scientific concepts behind the genetics and molecular makeup of cancer.

Szent-Györgyi Prize Recipients

Sources: NFCR, NFCR

Year Recipient Title/Organization Notes Ref(s)
2006 Harold F. Dvorak, M.D. Mallinckrodt Professor Emeritus of Pathology at Harvard Medical School
Chief of the Department of Pathology at Beth Israel Deaconess Medical Center		 [2]
2007 Webster K. Cavenee, Ph.D. Director of the Ludwig Institute for Cancer Research, San Diego Branch
Distinguished Professor at the University of California, San Diego		 Member of the National Academy of Sciences and the Institute of Medicine of the National Academies
2008 Carlo M. Croce, M.D. Director of the Human Cancer Genetics Program and Director of the Institute of Genetics at Ohio State University Member of the National Academy of Sciences and the Institute of Medicine of the National Academies
2009 Ronald A. DePinho, M.D. Professor and Director, Belter Institute Department of Medicine and Genetics, Dana-Farber Cancer Institute and Harvard Medical School Member of the National Academy of Sciences and Institute of Medicine of the National Academies
2010 Peter K. Vogt, Ph.D. Professor in the Department of Molecular and Experimental Medicine, The Scripps Research Institute Member of the American Academy of Arts and Sciences, the National Academy of Sciences, the Institute of Medicine of the National Academies, and the American Academy of Microbiology
2011 Beatrice Mintz, Ph.D. Professor and Jack Schultz Chair in Basic Science, Fox Chase Cancer Center. Member of the National Academy of Sciences and the Pontifical Academy of Sciences
2012 Zhen-Yi Wang, M.D. Professor at the School of Medicine of Shanghai Jiao Tong University
Honorary Director of the Shanghai Institute of Haematology		 Member of the Chinese Academy of Engineering and the French Academy of Sciences
Zhu Chen, M.D., Ph.D. Minister of Health of the People's Republic of China
Professor at the School of Medicine of Shanghai Jiao Tong University		 Member of the Chinese Academy of Sciences, the National Academy of Sciences, the Institute of Medicine, the French Academy of Sciences, the Third World Academy of Sciences, and the European Academy of Sciences and Arts
2013 Alex Matter, M.D. Awarded for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer
2014 James P. Allison, Ph.D. Chairman, Department of Immunology at the University of Texas MD Anderson Cancer Center Member of the National Academy of Sciences and the Institute of Medicine of the National Academies
2015 Frederick Alt, Ph.D. Professor of Genetics at Harvard Medical School
Director of the Program in Cellular and Molecular Medicine at Boston Children’s Hospital		 Howard Hughes Medical Institute Investigator
2016 Mary-Claire King, Ph.D. Professor of Medicine (Medical Genetics) and Genome Sciences at University of Washington
2017 Michael N. Hall, Ph.D. Professor of Biochemistry at Biozentrum University of Basel
2018 Douglas R. Lowy Center for Cancer Research at the National Cancer Institute [3]
John T. Schiller [3]
2019 Steven Rosenberg, M.D., Ph.D. Chief of the National Cancer Institute Center for Cancer Research’s surgery branch in Bethesda [4]
2020 Susan Band Horwitz, Ph.D. Professor and Rose C. Falkenstein Chair in Cancer Research at the Albert Einstein College of Medicine [5]
2021 Mark M. Davis, Ph.D. Professor of microbiology and immunology at the Stanford University [6]
Tak Wah Mak, Ph.D. Senior scientist at the Princess Margaret Cancer Centre
University professor at the University of Toronto		 [6]
2022 Rakesh K. Jain, Ph.D. Professor of Tumor Biology at Massachusetts General Hospital in the Harvard Medical School
2023 Isaac Witz, Ph.D. Professor of immunology and cancer research at Tel Aviv University [7]
2024 Dennis Slamon Oncologist and chief of the division of Hematology-Oncology at UCLA [8]

See also

References

  1. ^ "Szent-Györgyi Prize". National Foundation for Cancer Research. Archived from the original on 15 February 2017. Retrieved 8 November 2016.
  2. ^ National Foundation for Cancer Research. N.p., n.d. Web. 29 Jan. 2013.
  3. ^ a b "Szent-Györgyi Prize to honor NCI's Douglas R. Lowy and John T. Schiller". National Cancer Institute. 15 February 2018. Retrieved 4 October 2019.
  4. ^ "Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research". National Foundation for Cancer Research. 12 February 2019. Retrieved 24 February 2021.
  5. ^ "2020 Szent-Gyorgyi Prize Awarded to a Pioneering Researcher Who Has Unlocked Workings of Cancer Drugs of Natural Product Origin". National Foundation for Cancer Research. 13 February 2020. Retrieved 24 February 2021.
  6. ^ a b "2021 Szent-Györgyi Prize Awarded to Pioneering Research Duo Who Have Paved the Path to Life-Saving T-Cell Receptor-Based Cancer Immunotherapies". National Foundation for Cancer Research. 18 February 2021. Retrieved 24 February 2021.
  7. ^ "Prof. Isaac P. Witz Honored with 2023 Szent-Györgyi Prize for Progress in Cancer Research".
  8. ^ "UCLA oncologist Dr. Dennis Slamon awarded Szent-Györgyi Prize for groundbreaking research discoveries | UCLA Health". www.uclahealth.org. Retrieved 2025-04-28.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.